funding-eu EU Horizon Europe HORIZON-HLTH-2027-01 HORIZON-HLTH-2027-01-CARE-02 Biobanks Clinical Pharmacology Co-morbidity

Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

EU — Italia · scadenza 13/04/2027

Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

Scadenza: 13/04/2027

Fonte: eu_funding_tenders

Tipo: EU

Pagina ufficiale: Apri la scheda sulla fonte ufficiale

Scheda (fonte ufficiale)

Topic metadata

EU Programme: Horizon Europe (ID 43108390)
Call identifier: HORIZON-HLTH-2027-01
Call name: Cluster 1 - Health (Single stage - 2027/1)
Type: Topic
Opening date: 10/02/2027
Next deadline: 13/04/2027
Keywords: HORIZON-HLTH-2027-01-CARE-02, HORIZON-HLTH-2027-01, Biobanks, Clinical Pharmacology, Co-morbidity, Health data, Personalised services, Personalised treatment

Topic description

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Ensuring equal access to innovative, sustainable, and high-quality healthcare”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:

Patients benefit from decreased incidence of Adverse Drug

Iscriviti o accedi per leggere e ricevere aggiornamenti sui finanziamenti.

Iscriviti ora